
Aveanna Healthcare Holdings (AVAH) put fresh numbers on the table on November 12 with third quarter results, updated full year guidance, and new detail on recent impairment charges.
The earnings beat and raised guidance came alongside a sharp reversal in Aveanna Healthcare Holdings’ recent trading. The stock dropped 6.1% on the day of the release and is down 13.2% over the past week, yet the share price return year to date is up 42.3%. The 3 year total shareholder return is very large, indicating strong long run compounding even as short term momentum has cooled.
Scan how Aveanna Healthcare Holdings compares on value and momentum next to other home-care and healthcare providers by reviewing the hand-picked 32 high quality undervalued stocks right after results like these.
Aveanna Healthcare Holdings just posted strong Q3 figures, yet the share price has pulled back after a big multi year run. Is most of the rerating already behind the stock, or is valuation still pointing to more runway ahead?
Aveanna Healthcare Holdings closed at $11.50 on November 12, while the analyst consensus Narrative on Simply Wall St anchors fair value at $15.05 based on detailed revenue and earnings assumptions. That framework hinges less on a simple multiple and more on contract mix, reimbursement visibility and how free cash flow is deployed over time.
The main thing that has to go right is continued execution on preferred payer and episodic contracting, along with disciplined use of free cash flow and acquisitions, so that Aveanna Healthcare Holdings can extend its shift toward higher quality revenue while reducing leverage toward management’s sub 3x target.
The current valuation implies that the market is not fully pricing in Aveanna Healthcare Holdings’ mix shift toward preferred and episodic contracts, its reported free cash flow generation and deleveraging, and the potential impact of recently raised long term organic growth targets and upcoming rate improvements.
See why 7 investors see Aveanna Healthcare Holdings as 24% undervalued.
Result: Fair Value of $15.05 (UNDERVALUED)
Still, the Aveanna Healthcare Holdings story could be knocked off course if wage pressure squeezes caregiver availability or if Medicaid and Medicare rate decisions turn less favorable than analysts currently model.
Find out about the key risks to this Aveanna Healthcare Holdings narrative.
If this mix of optimism and concern around Aveanna Healthcare Holdings resonates, consider acting promptly and evaluate the trade off yourself by reviewing the 4 key rewards and 3 important warning signs.
Do not stop with Aveanna Healthcare Holdings. Use the Simply Wall St screener to find fresh opportunities other investors may be overlooking right now.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com